Skip to main content
logo
Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
21.92
-0.82 (-3.61%)
Oct 6, 2026, 1:35 PM EDT - Market open

Assembly Biosciences Revenue

Assembly Biosciences had revenue of $13.37M in the quarter ending June 30, 2026, with 38.94% growth. This brings the company's revenue in the last twelve months to $74.85M, up 125.12% year-over-year. In the year 2025, Assembly Biosciences had annual revenue of $72.30M with 153.52% growth.

Revenue (ttm)
$74.85M
Revenue Growth
+125.12%
P/S Ratio
6.06
Revenue / Employee
$1,025,274
Employees
73
Market Cap
446.30M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202572.30M43.78M153.52%
Dec 31, 202428.52M21.36M298.16%
Dec 31, 20237.16M--
Dec 31, 2022---
Dec 31, 20216.25M-72.85M-92.09%
Dec 31, 202079.11M63.14M395.55%
Dec 31, 201915.96M1.16M7.83%
Dec 31, 201814.80M5.79M64.14%
Dec 31, 20179.02M--
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Arvinas316.70M
Puma Biotechnology231.24M
REGENXBIO174.48M
Autolus Therapeutics117.39M
Prothena Corporation54.53M
Ovid Therapeutics1.58M
Revenue Rankings

ASMB News

More News